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Genome-wide studies have identified thousands of
long noncoding RNAs (lncRNAs) lacking protein-
coding capacity. However, most lncRNAs are ex-
pressed at a very low level, and in most cases there
is no genetic evidence to support their in vivo func-
tion.Malat1 (metastasis associated lung adenocarci-
noma transcript 1) is among the most abundant
and highly conserved lncRNAs, and it exhibits an
uncommon 30-end processing mechanism. In addi-
tion, its specific nuclear localization, developmental
regulation, and dysregulation in cancer are sugges-
tive of it having a critical biological function. We
have characterized aMalat1 loss-of-function genetic
model that indicates that Malat1 is not essential for
mouse pre- and postnatal development. Further-
more, depletion of Malat1 does not affect global
gene expression, splicing factor level and phosphor-
ylation status, or alternative pre-mRNA splicing.
However, among a small number of genes that
were dysregulated in adult Malat1 knockout mice,
many were Malat1 neighboring genes, thus indi-
cating a potential cis-regulatory role of Malat1 gene
transcription.INTRODUCTION
Recent genome-wide studies have indicated that the majority of
the human and mouse genomes are transcribed, yielding a
complex network of transcripts that includes thousands of non-
coding RNAs (ncRNAs) with no protein-coding capacity (Chodr-
off et al., 2010; Guttman et al., 2009; reviewed in Kapranov et al.,
2007; Ørom et al., 2010). Long noncoding RNAs (lncRNAs), the
largest and most complex class of ncRNAs, are mRNA-like
RNA polymerase II transcripts ranging in size from 200 nt
to >100 knt, and many exhibit cell-type-specific expression(Chodroff et al., 2010; Guttman et al., 2009; Orom et al., 2010).
The majority of lncRNAs are expressed at very low levels,
some as low as one or less than one copy per cell (Mercer
et al., 2012), and these RNAs generally exhibit poor primary
sequence conservation over evolution. LncRNAs have been
implicated in numerous molecular functions, including modu-
lating transcriptional patterns, regulating protein activities,
serving structural or organizational roles, altering RNA process-
ing events, and serving as precursors to small RNAs (reviewed in
Wilusz et al., 2009). However, most of these molecular functions
were deduced from studies performed in cell lines upon lncRNA
overexpression or knockdown. Except for a few examples, such
as Xist involved in X chromosome inactivation (Marahrens et al.,
1997) and Kcnq1ot1 (Mohammad et al., 2010) and Air (Sleutels
et al., 2002) in genomic imprinting, genetic evidence supporting
the in vivo function of most mammalian lncRNAs is lacking.
The lncRNA HOTAIR has recently been studied in knockdown
cell lines and shown to regulate expression of HoxD genes in
trans by associating with chromatin modification complexes
such as PRC2, LSD1, and CoREST/REST (Khalil et al., 2009;
Rinn et al., 2007; Tsai et al., 2010) and to be overexpressed in
breast cancer and regulate metastasis by reprogramming chro-
matin via polycomb complexes (Gupta et al., 2010). Interestingly,
genetic deletion of the mouse HoxC cluster containing the Hotair
gene did not result in misregulation ofHoxD genes or any pheno-
type at the molecular or organismal level (Schorderet and
Duboule, 2011). Noncoding nuclear-enriched abundant tran-
script 1 (Neat1, a.k.a. Men ε/b) lncRNA has been shown to be
essential for the assembly and maintenance of nuclear para-
speckles (Clemson et al., 2009; Mao et al., 2011; Sasaki et al.,
2009; Sunwoo et al., 2009) and nuclear retention of some hyper-
edited RNAs in hESCs and HeLa cells (Chen and Carmichael,
2009). Surprisingly, a study of Neat1 hypomorphic mouse
mutants, although lacking paraspeckles, failed to exhibit any
physiological defects (Nakagawa et al., 2011). While these
lncRNAs do not appear to be essential during pre- or postnatal
mouse development, their regulatory function may be masked
by redundant or compensatory mechanisms and may only be
revealed upon specific stress conditions, which have thus far
not been investigated. Interestingly, a recent study in zebrafishCell Reports 2, 111–123, July 26, 2012 ª2012 The Authors 111
identified 29 evolutionarily conserved lncRNAs, and of these,
two exhibited a significant regulatory function during zebrafish
development, as demonstrated by morpholino intervention
(Ulitsky et al., 2011). Further in vivo analyses of lncRNAs are
necessary to reveal their mechanisms of action.
Malat1 (metastasis associated lung adenocarcinoma tran-
script 1), also known as Neat2 (noncoding nuclear-enriched
abundant transcript 2), is located on mouse chromosome
19qA (human chromosome 11q13.1). Malat1 is evolutionarily
conserved among mammals in terms of its primary sequence,
and it is highly expressed in many tissues and regulated during
tissue differentiation (Bernard et al., 2010; Hutchinson et al.,
2007; Ji et al., 2003). MALAT1 is also upregulated in several
human cancers, suggesting that it may have an important func-
tion during cancer progression (Guffanti et al., 2009; Ji et al.,
2003). Knockdown of MALAT1 by antisense oligonucleotides
(ASOs) has been shown to affect the recruitment of pre-mRNA
splicing factors to a reporter locus in human U2OS cells and to
alter synapse number in cultured neurons (Bernard et al.,
2010). Recently, MALAT1 depletion in HeLa cells was shown
to perturb the protein level and phosphorylation status of two
pre-mRNA splicing factors and the pre-mRNA splicing pattern
of a set of transcripts (Tripathi et al., 2010). In addition, a large
fraction of cells accumulated at the G2/M boundary and an
increased cell death was observed (Tripathi et al., 2010). In
contrast, a second study examining the effect of knockdown of
MALAT1 in HeLa cells observed a loss of serum-induced cell
proliferation and E2F1 target gene expression with profound
G1/S arrest, but no apparent G2/M arrest or cell death (Yang
et al., 2011). MALAT1 was shown to be part of a complex that
binds to unmethylated Pc2 at nuclear speckles promoting
E2F1 SUMOylation, leading to activation of the growth-control
gene program (Yang et al., 2011). However, the physiological
function of Malat1 lncRNA at the tissue and organismal levels
has not been investigated.
Here, we show that Malat1 is one of the most abundant
lncRNAs in mouse liver and brain cortex. To assess the potential
in vivo function of mouse Malat1, we first evaluated the conse-
quences of its knockdown in adult mice by using an antisense
approach and found no significant morphologic change in tissue
organization upon its transient depletion. The Malat1 locus is
syntenically conserved from fish to human, and its high tran-
scription rate is also maintained through evolution despite
limited sequence conservation, suggesting that transcription of
the Malat1 gene per se may carry a biological function. To
examine the role of the Malat1 gene locus, we also established
a mouse loss-of-function genetic model. Detailed whole-body
histopathologic characterization showed that Malat1 ncRNA
and its transcription are dispensable for mouse pre- and post-
natal development. Further cell biological and biochemical anal-
yses indicated that Malat1 lncRNA is not essential for nuclear
speckle assembly/maintenance, the level and phosphorylation
status of serine/arginine-rich (SR) splicing factors, or cell pro-
liferation and viability. Genome-wide expression and splicing
profiling of mouse liver and brain cortex demonstrated that
Malat1 loss results in minimal alterations in global gene expres-
sion and pre-mRNA splicing. However, inactivation of theMalat1
gene results in a nearly 2-fold upregulation of several genes that112 Cell Reports 2, 111–123, July 26, 2012 ª2012 The Authorsreside adjacent to theMalat1 locus, including the lncRNA Neat1.
These results suggest a model whereby transcription by the
highly active Malat1 promoter may be important for regulating
the expression of nearby genes in cis.
RESULTS
Malat1 Encodes a Highly Abundant lncRNA in Mouse
To assess the level of Malat1 lncRNA in mouse, we performed
RNA-seq profiling and obtained 230 and 220 million paired-
end reads from three wild-type mouse livers and three brain
cortices, respectively. We first focused on profiles of 1,700
lncRNA genes in RefSeq (see Experimental Procedures).
Consistent with previous findings, we found that most lncRNA
genes are expressed at lower levels as compared to protein-
coding genes (Figures 1A and 1B). However, the fragments per
kilobase million reads (FPKM) value for Malat1 is comparable
or higher than several housekeeping protein-coding genes (in
liver: Malat1, 109 FPKM; Actb, 177 FPKM; Gapdh, 21 FPKM; in
brain cortex: Malat1, 199 FPKM; Actb, 484 FPKM; Gapdh, 16
FPKM).Malat1 is highly expressed in both brain cortex and liver
(Figures 1A–1C and Table S1) and comprises 15.2% of total
lncRNA sequence reads in liver and 5.7% in brain cortex.
Interestingly, the Malat1 gene resides adjacent to Neat1,
another lncRNA gene on mouse Chr.19 (Figure 1D). The
nuclear-retained Malat1 ncRNA is 6.7 knt (kilonucleotide) and
the nuclear retained Neat1 RNA exists as two isoforms of 3.2
knt (Neat1_1) and 20 knt (Neat1_2) (Sunwoo et al., 2009) (Fig-
ure 1D). Conservation analysis showed that both Malat1 and
Neat1_1 are among the most conserved lncRNAs during verte-
brate evolution (data not shown) withminimal repetitive elements
(Figure 1D). Similar to Malat1, Neat1 is also highly and widely
expressed in adult tissues (Figures 1A–1C) (Hutchinson et al.,
2007). A recent study has shown that both RNA molecules
have a unique 30 end processing module, which is conserved
from fish to human (Figure 1D) (Sunwoo et al., 2009; Wilusz
et al., 2008). Malat1 and Neat1 nascent RNAs are each pro-
cessed by RNases P and Z to produce nuclear-retained ncRNAs
and small cytoplasmic RNAs (mascRNA from Malat1, menRNA
from Neat1) that exhibit a tRNA-like structure (Sunwoo et al.,
2009; Wilusz et al., 2008) (Figure 1D). RNA fluorescence in situ
hybridization (FISH) demonstrated that Neat1 RNA localizes to
nuclear regions in close proximity to Malat1 RNA in mouse
embryo fibroblasts (MEFs) as well as interstitial cells of testis
(Figures 1E and 1F), consistent with the previously reported
localization of these RNAs in nuclear speckles (Malat1) and para-
speckles (Neat1) of cultured cells (Clemson et al., 2009; Hutchin-
son et al., 2007; Mao et al., 2011; Sasaki et al., 2009; Sunwoo
et al., 2009). Northern blot analyses showed that both Malat1
and Neat1 are nuclear retained in MEFs (Figure 1G), consistent
with previous findings (Hutchinson et al., 2007), and that both
mascRNA and menRNA are detected in mouse liver (Figure 1H)
and kidney (data not shown). In contrast to a previous finding
indicating that menRNA is unstable in cultured cells due to a
noncanonical CCACCA addition at its 30 end (Wilusz et al.,
2011), our data suggest that menRNA generated in liver and
kidney is a stable small RNA exhibiting the classical CCA addi-
tion (Figure S1). However, in wild-type mouse brain, while we
Figure 1. Malat1 Encodes a Highly Abundant lncRNA in Vertebrates
(A and B) RNA-seq transcriptome analyses of mouse brain cortex and liver. Note that Malat1 and Neat1_1 are among the most abundant lncRNAs and that
expression of Malat1 in both cortex and liver is higher than that of most protein-coding genes.
(C) Tissue-specific expression of lncRNA genes. x and y axes indicate log2(FPKM) values of lncRNAs in cortex and liver, respectively.
(D) The reverse strand of the genomic locus of mouse chr19:5,760,586-5,860,585.Malat1 is40 kb downstream ofNeat1. Frmd8 and Scyl1 are adjacent protein-
coding genes.
(E and F) RNA FISH shows that bothMalat1 (red) and Neat1 (green) occupy distinct subnuclear domains in MEFs (E) and interstitial cells of testis (F). Blue, DAPI
staining. Scale bars represent 5 mm.
(G) Northern blot analysis shows thatNeat1_1 andMalat1 are enriched in the nuclear fraction and that b-actin is distributed in both cytosolic and nuclear fractions.
(H) Small RNA northern blot analysis shows that menRNA and mascRNA are detected in mouse liver. U6 is the loading control. Note that the blot in (H) is the
same as that used in lanes 3 and 4 in Figure 3E to avoid cross-hybridization of the menRNA probe to mascRNA.saw relatively high level ofmascRNA,menRNA is not detectable
(data not shown). This is most likely due to the lower expression
of the long isoform of Neat1 (Neat1_2) in brain, as observed
by northern blot (data not shown) and RNA-seq analyses
(Neat1_2: 0.44 FPKM in liver, 0.04 FPKM in cortex; Figure 1C).
Collectively, our results demonstrate that Malat1 lncRNA is ex-
pressed at a very high level, processed at its 30 end to generate
mascRNA, and localized in distinct subnuclear domains in
mouse tissues as well as cultured cells.
Antisense Knockdown ofMalat1 ncRNA in Adult Mice
Does Not Alter Organ Organization
The high abundance, strong evolutionary conservation, specific
subcellular localization, and developmental regulation of Malat1suggest significant in vivo biological functions. However, such
function could be derived from either the Malat1 RNA transcript
itself or the act of transcriptional activity of the Malat1 gene.
To distinguish between these two possibilities, we first exam-
ined the functional consequence of in vivo depletion of Malat1
lncRNA. Malat1 ASOs were administered into adult mice sub-
cutaneously and the knockdown efficiency was examined by
quantitative RT-PCR (qRT-PCR) and RNA in situ hybridization
(ISH) (Figures 2A–2H). As compared with saline-treated
animals, significant Malat1 knockdown was observed in both
liver (97%–98% knockdown; Figure 2G) and small intestine
(86%–95% knockdown; Figure 2H) from animals treated with
Malat1 ASO1 or ASO2. Knockdown of Malat1 with either of
these ASOs does not alter the overall expression level ofCell Reports 2, 111–123, July 26, 2012 ª2012 The Authors 113
Figure 2. Antisense Knockdown of Malat1
lncRNA in Adult Mice Does Not Alter Organ
Organization
(A and B) ISH analysis ofMalat1 on saline-treated
or Malat1 ASO1-treated livers. Malat1 is highly
expressed in most liver cells (A), with its signal
enriched in nuclei (inset of A). ASO1 efficiently
knocks downMalat1 expression in most liver cells
(B), and the remaining signals form a few distinc-
tive dots in nuclei (arrows, inset of B), which are
most likely the nascent transcripts at the tran-
scription sites of the Malat1 gene locus.
(C) As a negative control, probe-free ISH on
the saline-treated liver shows no hybridization
signal.
(D and E) ISH analysis ofMalat1 on saline-treated
or Malat1 ASO1-treated small intestine. Malat1
is highly expressed in most small intestine cells
(D), with its signal enriched in nuclei. ASO1 effi-
ciently knocks down Malat1 expression in most
cell types (E).
(F) As a negative control, probe-free ISH on the
saline-treated small intestine shows no hybrid-
ization signal. Scale bars represent 100 mm.
(G and H) qRT-PCR analyses show that Malat1
ncRNA is significantly knocked down in ASO-
treated liver (G) and small intestine (H), while
Neat1 ncRNA exhibits no significant change upon
Malat1 depletion in both liver (G) and small intes-
tine (H). ISH, in situ hybridization; ASO, antisense
oligonucleotide; Ctrl, control. Error bars represent
SD. *p < 0.05, Student’s unpaired t test.Neat1 in liver or small intestine (Figures 2G and 2H). ASO1
was slightly more effective than ASO2 in both liver and small
intestine. In liver, Malat1 depletion in hepatocytes was more
dramatic than in bile duct epithelial cells (data not shown). In
small intestine, Malat1 knockdown in villi epithelial cells was
more effective than in crypts and lamina propria (Figures
2D–2F). No detectable Malat1 signal was observed in saline-
treated tissues incubated without Malat1 probes (Figures 2C
and 2F). Although significant knockdown was achieved, no
noticeable abnormality was seen in serum chemistry and
tissue morphology between Malat1 ASO and control, PBS-
treated mice.
Generation and Characterization of a Malat1/ Mouse
Model
As in vivo knockdown studies did not reveal a function forMalat1
lncRNA in adult mice, we developed a knockout mouse to delin-
eate its potential role during early development and to assess
whether the direct function of the Malat1 gene is the act of its
transcription. Toward this end, we generated Malat1 mutant
mice using homologous recombination in ESCs (Figure 3A).
We found the recombination rate at the Malat1 locus to
be 36% (24 recombination positives from 67 clones), higher114 Cell Reports 2, 111–123, July 26, 2012 ª2012 The Authorsthan other loci in the genome. This is
consistent with previous reports of the
high susceptibility for translocation and
DNA damage, and an exceptionally hightranscriptional activity at the Malat1 locus (Davis et al., 2003;
Ferris et al., 2010; Kato et al., 2012; Rajaram et al., 2007).
The mutant mice, lacking a 3 kb genomic region containing
the 50 end of theMalat1 gene and its promoter, were genotyped
by Southern blotting and tail DNA PCR analyses (Figures 3B and
3C). Northern blotting analysis using a2 kb partial cDNA probe
showed that the Malat1 transcript is completely depleted in
Malat1/ tissues (Figure 3D). In addition, small RNA northern
blotting analysis using an oligonucleotide probe demonstrated
that mascRNA is absent in Malat1/ kidney and liver, but is
detectable in Malat1/ brain at a significantly lower level as
compared to that in wild-type brain (Figure 3E). The minimal
amount ofmascRNA in mutant brain may be the result of a tran-
script derived from a brain-specific promoter upstream of the
30 tRNA-like structure. However, we did not see any other RNA
bands of a different size recognized by a Malat1 partial cDNA
probe in both wild-type and mutant brains (Figure 3D).
Since knockdown of Malat1 in human HeLa cells was previ-
ously shown to result in alterations in alternative pre-mRNA
splicing and cell death (Tripathi et al., 2010), we expected that
homozygous deletion of Malat1 would result in aberrations
in pre- and/or postnatal development or tissue maturation.
However, Malat1/ mice are grossly normal and fertile. The
Figure 3. Generation and Characterization
of a Malat1 Knockout Mouse
(A) The strategy for Malat1 targeting using
homologous recombination. E, EcoRI; S, SalI; N,
NotI; B, BglII; X, homologous recombination; p1,
p2, p3, p4, p5, PCR primers; red line, 30 external
probe for Southern blot analysis.
(B and C) Southern blot (B) and PCR (C) analyses
show detection of wild-type and Malat1 mutant
alleles.
(D) Northern blot analyses show that Malat1
lncRNA is depleted in homozygous mutant brain
and liver. 28S and 18S indicate the positions of
their size.
(E) Small RNA northern blot analyses using oligo
probe show that mascRNA is depleted in Malat1
mutant liver and kidney and that a small amount of
mascRNA is detected in the mutant brain. *,
nonspecific bands. b-actin and U6 are the loading
controls.offspring of heterozygous breedings follow Mendelian segrega-
tion (Figure S2A), suggesting that deletion of Malat1 does not
affect mouse pre- and postnatal viability. Breedings between
Malat1 homozygotes and wild-type produce normal-sized litters
(Figure S2A), indicating that Malat1/ mice are fertile. A large
number of tissues from wild-type and mutant mice were as-
sessed for potential histopathological alterations upon Malat1
deletion. No obvious gross phenotypes were observed in
mutants (Figures S2B–S2G). Blood cell counts and chemistry
did not show any significant defects in Malat1 mutant mice
(data not shown). We also performed immunohistochemical
labeling of Ki67 and Cleaved Caspase3 and did not see any
significant difference in terms of the number of proliferating or
apoptotic cells between wild-type and mutant tissue sections
(data not shown). This is in stark contrast to cell death and
growth arrest induced by Malat1 knockdown using ASOs or
RNAi in human and mouse cell lines (Tripathi et al., 2010; Yang
et al., 2011). Together, these data suggest that neither Malat1
nor its transcription is essential for mouse development, viability,
and fertility under normal physiological and environmental
conditions. However, it remains to be determined whether
Malat1 and/or its transcriptional activity are required under
specific stress conditions or whether functional redundancy
exists in the mouse.
Malat1 lncRNA Is Not Necessary for the Establishment
or Maintenance of Nuclear Speckles
Malat1 lncRNA localizes to nuclear speckles and interacts with
nuclear-speckle-associated proteins such as SRSF1 (Hutchin-Cell Reports 2, 111–1son et al., 2007; Tripathi et al., 2010), sug-
gesting a potential function for Malat1 in
nuclear speckle assembly and/or main-
tenance. To investigate the effects of
loss of Malat1 lncRNA on nuclear
speckles, we isolated MEFs. No prolifer-
ation or apoptotic defects were seen in
mutant MEFs as compared to wild-type
(data not shown). RNA FISH and qRT-PCR analyses indicated that Malat1 lncRNA is completely
depleted from the mutant MEFs while its neighboring lncRNA
Neat1 is slightly upregulated and forms two paraspeckle clus-
ters, presumably around its transcription sites (Figures 4A–4C).
To examine whether loss of Malat1 lncRNA affects nuclear
speckle or paraspeckle morphology, we performed immunofluo-
rescence (IF) labeling for these nuclear domains, using anti-
bodies against SRSF2 and PSP1a in MEFs. We found that
Malat1 deletion has no overall effect on the number, size, and
distribution of either nuclear speckles (Figures 4D and 4E) or
paraspeckles (Figure S3).
Loss of Malat1 Does Not Alter the Level
and/or Phosphorylation Status of SR Proteins
Nuclear speckles are characterized by the enrichment of pre-
mRNA splicing factors, including those of the SR family and
small nuclear ribonucleoprotein complexes (reviewed in Lamond
and Spector, 2003). It has been previously reported that Malat1
knockdown in HeLa cells alters the level and phosphorylation
status of two SR proteins, resulting in changes in the alternative
splicing pattern of certain pre-mRNAs, and significant G2/M
arrest and cell death (Tripathi et al. 2010). Since Malat1 mutant
mice are fertile and do not exhibit any obvious cellular or tissue
defects, we examined the phosphorylation status of SR family
members in wild-type versus mutant mice. Initially, the status
of SR protein phosphorylation in MEFs was evaluated by immu-
noblot and probing against members of the SR family, including
SRSF1, with the use of a phospho-epitope specific antibody
(3C5) that recognizes the conserved serine arginine residues of23, July 26, 2012 ª2012 The Authors 115
Figure 4. Depletion ofMalat1 lncRNADoes Not AlterNeat1 Localization or Nuclear SpeckleMorphology or the Phosphorylation Status of SR
Proteins
(A and B) RNA FISH shows the subnuclear distribution ofMalat1 (red) and Neat1 (green) in wild-type (A) andMalat1/ (B) MEFs. Note that Neat1 ncRNAs form
two nuclear clusters adjacent to Malat1 ncRNAs. Blue, DAPI staining.
(C) qRT-PCR analysis shows thatMalat1 ncRNA is depleted inMalat1/ MEFs, while Neat1 ncRNA exhibits no significant change in the mutants as compared
to wild-type. Error bars represent SD. *p < 0.05, Student’s unpaired t test.
(D and E) Immunofluorescence labeling of SRSF2(SC35) for nuclear speckles shows no significant changes of nuclear speckle morphology, distribution, and
number in the mutant (E) as compared to wild-type (D) MEFs. Blue, DAPI staining.
(F) Western blot analyses of phospho SR proteins labeled by 3C5 antibody and total SRSF1 labeled by anti-SRSF1 show no change of SR protein level or
phosphorylation status in the mutant as compared to wild-type MEFs. b-actin is the loading control. Scale bars represent 5 mm.
(G) Western blot analyses of phospho SR proteins show no changes of SR protein phosphorylation status or total SRSF1 level in brain, lung, liver, and testis from
the mutant as compared to wild-type. b-actin is the loading control.
(H) qRT-PCR analysis shows that free-uptake ASO againstMALAT1 knocks downMALAT1 lncRNA by 80% compared to the control ASO (Ctrl) in MCF7 cells.
Error bars represent SD. *p < 0.05, Student’s unpaired t test.
(I) Western blot analyses of phospho SR proteins show no changes of SR protein phosphorylation status or protein level in MCF7 cells treated with theMALAT1
ASO compared to the control ASO (Ctrl).SR family members of splicing factors (Turner and Franchi,
1987). We did not observe any alteration in the level or phosphor-
ylation status of SR proteins, including SRSF1, in Malat1/
MEFs as compared to wild-type (Figure 4F).
Next, we examined the phosphorylation status of these SR
proteins in adult tissues of wild-type and mutant mice, and we
found that there is no change in the total pool of phosphorylated116 Cell Reports 2, 111–123, July 26, 2012 ª2012 The Authorssplicing factors and that the level of SRSF1 remained the same in
each of the tissues (adult brain, lung, liver, and testis) of wild-type
andMalat1mutant samples (Figure 4G). Immunofluorescence of
SRSF2 in wild-type and mutant MEFs also did not show any
change in nuclear speckle number or morphology (Figures 4D
and 4E). The speckled pattern was also studied in adult mouse
tissue sections by immunofluorescence using SRSF2 antibody,
and cells exhibited no change in the number or pattern of nuclear
speckles inMalat1/ tissues as compared towild-type (data not
shown). These observations clearly demonstrate that Malat1
loss does not result in a change in the level or phosphorylation
status of SR splicing factors or the association of SRSF2 with
nuclear speckles in vivo.
This was very surprising, given the fact that in HeLa cells,
knockdown of Malat1 had a profound effect on splicing factor
phosphorylation status (Tripathi et al., 2010). AsMalat1 is among
the most conserved lncRNAs in mammals, it is highly unlikely
that it will have a different function between mouse and human.
To address this discrepancy, we repeated the Malat1 knock-
down experiment in human HeLa cells by using lipofectamine
2000-mediated transfection of ASOs. While knockdown of
Malat1 at 48 hr and 72 hr after transfection resulted in dephos-
phorylation of SRSF1 (Figure S4) accompanied by significant
cell death, SRSF1 phosphorylation changes and cell death
were also observed at some level in control ASO-transfected
cells 72 hr after treatment. However, similar knockdown experi-
ments using Fugene, a less toxic lipid reagent, resulted in no
significant cell death after 48 hr and minimal cell death after
72 hr in both control ASO and MALAT1 ASO treated human
MCF7 cells (data not shown). To further confirm that knockdown
of MALAT1 in cultured cells does not cause cell death and
alter SR phosphorylation status, we used ASOs with a MOE
gapmer structure, which can be taken up effectively by some
cultured cell lines without transfection reagents. The MALAT1
knockdown using ASOs at 75 nM concentration in MCF7 cells
reached a level of 80%–90% RNA reduction after 48 hr (Fig-
ure 4H), which is comparable to that of ASO knockdown using
lipid transfection reagents. The MALAT1 knockdown by free
uptake ASOs did not alter the phosphorylation status of SR
proteins and the SRSF1 level at the 48 hr time point inMCF7 cells
(Figure 4I) and did not result in cell death at the 72 hr time point
(data not shown). We also see no effects of Malat1 knockdown
on SR phosphorylation in human SW480 (Figure S4) and
MCF10A cells or in mouse mammary tumor 4T1, 4T07, 67NR,
and 168FARN cells (data not shown). Taken together, MALAT1
loss in and of itself does not result in changes in the level
of SRSF1 or the phosphorylation status of SR proteins, or in
cell death in many human and mouse cell lines as well as in
mouse tissues.
Malat1 lncRNA Does Not Regulate Global Pre-mRNA
Splicing
While depletion of Malat1 RNA in mouse tissues does not alter
nuclear speckle morphology or cause any significant changes
in SR protein level and phosphorylation, we were interested in
examining the effect of loss ofMalat1 on global gene expression
and alternative pre-mRNA splicing. To probe molecular changes
in Malat1 mutant tissues, we performed RNA-seq profiling and
obtained 70 million paired-end reads for each sample (liver:
3 wild-types and 3 mutants; brain cortex: 3 wild-types and
3 mutants; data from wild-type were used for the lncRNA abun-
dance quantification in Figure 1). We examined all (13,000)
cassette exons annotated in the mouse genome, which repre-
sent the most predominant pattern of alternative splicing, and
did not see global changes in the average inclusion levelbetween wild-type and Malat1 mutant livers (Figure S5A and
Figure 5A) or cortices (Figure S5B and Figure 5B). Only ten exons
in liver and five exons in brain cortex show statistically significant
changes (false discovery rate [FDR] < 0.05 and jDIj > 0.1; see
Experimental Procedures; Figures 5A and 5B), of moderate
magnitude and sometimes with substantial variation between
biological replicates. Therefore, Malat1 does not appear to
regulate global pre-mRNA splicing in adult mouse liver and
brain cortex.
Inactivation ofMalat1 Transcription Alters Local but Not
Global Gene Expression
It has been recently reported thatMalat1 interacts with unmethy-
lated Pc2 to promote E2F1 SUMOylation, resulting in relocation
of its downstream growth-control genes to nuclear speckles for
expression, and that knockdown of Malat1 inhibits cell growth
with a failure of these genes to reposition in the nucleus (Yang
et al., 2011). Malat1 knockdown has also been shown to alter
several synaptogenesis-associated genes in cultured Neuro2A
neuroblastoma cells (Bernard et al., 2010). To address whether
Malat1 regulates global gene expression, we compared expres-
sion levels of 1,700 lncRNAs and 19,000 protein-coding
genes in wild-type and mutant livers and brain cortices (see
Experimental Procedures). Interestingly, Malat1 lncRNA is
absent in mutant liver (wild-type, 109 FPKM; mutant, 0.1
FPKM) (Table S2) but still detectable at a very low level in mutant
brain cortex (wild-type, 199 FPKM; mutant, 2 FPKM) (Table S3).
RNA-seq reads ofMalat1 in mutant brain cortex were mapped to
a 3 kb region upstream ofmascRNA (data not shown), consis-
tent with the presence of a low level ofmascRNA in mutant brain
cortex (Figure 3E). It remains to be determined whether this 3 knt
transcript is expressed by an alternative promoter to compen-
sate for the loss of full-length Malat1 in mutant brain.
In both liver and cortex, no significant global changes in
steady-state mRNA level were detected (Figures 5C and 5D).
After multiple testing correction, only one gene (Saa3, serum
amyloid A 3) in liver and 12 genes in cortex showed statistically
significant changes between wild-type and Malat1 mutants
(Tables S2 and S3). However, we observed a bigger sex differ-
ence of gene expression in liver than in cortex (data not shown),
which might have masked some changes. For example, Neat1
shows higher expression in males and consistent 1.5- to
2-fold increases in Malat1 mutant livers in both sexes (Figures
S6A and S6B and Table S4A). When we compared gene expres-
sion in livers only from males, 22 genes, including Saa3 and
Upp2 (uridine phosphorylase 2), have statistically significant
changes between wild-type and Malat1 mutant liver samples
(Table S2).
Interestingly, among the 12 genes with significant expression
changes in brain cortex, five are adjacent to Malat1, including
Neat1, Frmd8, Tigd3, Ehbp1l1, and Ltbp3 (Figures 5E–5G; Table
S4B). All of these genes are upregulated 1.5- to 2.3-fold upon
inactivation of theMalat1 gene (Table S3). Upon further examina-
tion of other genes adjacent toMalat1 (240 kb region centered
around Malat1), we found seven additional genes, Map3k11,
Kcnk7, Fam89b, Scyl1, Slc25a45, Dpf2 and Cdc42ep2 whose
upregulation reaches statistical significance without genome-
wide multiple-testing correction (1.15- to 1.3-fold; Figure 5H;Cell Reports 2, 111–123, July 26, 2012 ª2012 The Authors 117
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Table S4B). Collectively, our data demonstrate that inactivation
of the Malat1 gene upregulates gene expression in cis but
does not alter global gene expression patterns in mouse liver
and cortex.
DISCUSSION
Genome-wide approaches have been successfully applied to
identify thousands of lncRNAs, some of which are transcribed
spatiotemporally. A complete understanding of their in vivo func-
tion(s) requires molecular and cell biological characterization as
well as the development of genetic models to assess their role(s)
at the more complex organismal level. Here, we have developed
a loss-of-function genetic model forMalat1, one of the most well
conserved and highly expressed lncRNAs. While Malat1 does
not have a direct role in mouse pre- and postnatal development,
inactivation of its transcription results in an upregulation of
a small number of adjacent genes.
Malat1 nascent transcripts are processed by RNases P and Z
to produce a 6.7-knt-long nuclear-retained ncRNA with a ge-
nomically encoded short polyA-like moiety at its 30 end and
a tRNA-like small RNA, mascRNA (Wilusz et al., 2008), that is
transported to the cytoplasm. Although Malat1 is highly abun-
dant in polyA(+) samples, given its lack of a traditional poly(A)
tail, it is very likely that our RNA-seq analysis of such samples
underestimates the abundance of Malat1. Consistent with this,
it has been reported that 0.4%–2.0% total sequencing reads
from the transcriptome profiling for ribo () RNA species in
a number of mouse tissues are mapped to the Malat1 gene
(Castle et al., 2010), indicating the high abundance and wide
expression pattern of this lncRNA.
The Malat1 gene is located on mouse chr.19qA (human
chr.11q13.1). Interestingly, 40 kb upstream of Malat1 in the
mouse genome, another lncRNA gene,Neat1, produces two iso-
forms with different 30 ends. The shortNeat1 transcript (Neat1_1)
is 3.2 knt, while the nascent long Neat1 transcript (Neat1_2) is
also processed by the tRNA processing machinery to produce
a nuclear retained 20-knt-long Neat1_2 transcript and
menRNA, a small tRNA-like RNA (Sunwoo et al., 2009). In
mammalian genomes, the primary sequences of both Malat1
andNeat1_1 are highly conserved and are nearly devoid of anno-
tated repeat-derived sequences, implying biological functions of
these RNAs. Neat1 is not computationally detected outside of
mammals; however, the Malat1 gene is syntenically conserved
in most sequenced gnathostome genomes (Stadler, 2010).
Except for the conserved 30 end processing module, the rest ofFigure 5. Malat1 RNA Does Not Regulate Global Pre-mRNA Splicing, b
(A and B) The volcano plot shows proportional change of inclusion level (x axis,DI)
depletion. Shaded regions represent statistically significant changes.
(C and D) The scatterplot shows the average expression of protein-coding (blue) a
Malat1 and Neat1_1 are highlighted.
(E) Malat1 is significantly depleted in Malat1 mutant brain cortexes.
(F and G) Neat1_1 and Frmd8 show consistent overexpression in mutant cortexe
(H) The240 kb genomic locus ofMalat1, with adjacent genes distributed in orde
multiple testing correction (red) and with statistical significance without multiple-te
bars under the wavy line represent transcription from the negative strand of the ch
strand.Malat1 lncRNA is surprisingly divergent, without homologous
fragments detected between fishes and mammals. Interestingly,
similar to that observed in human and mouse, the transcriptional
activity of the Malat1 gene in lizard, Xenopus, and zebrafish is
exceptionally high (B.Z. and D.L.S., unpublished data; Ulitsky
et al., 2011), suggesting that maintaining the high transcriptional
activity of the Malat1 locus during evolution may be important.
The strong constraint on the 30 end processing module during
the evolution of gnathostomes implies that the processingmech-
anism and/or its products may carry a biological role. However,
the functional carrier for the Malat1 locus during evolution is not
necessarily limited to only one component. Instead, it is very
likely to be combinations of the lncRNA transcript, the transcrip-
tion of the Malat1 gene, and/or the small mascRNA.
The chromatin structure at the Malat1-Neat1 genomic locus
exhibits several interesting features. (1) Transcription of these
two lncRNA genes is very active (Castle et al., 2010), and in
some cell types, RNA Pol II binding at their promoters is
extremely high as compared to the entire genome (Martianov
et al., 2010). (2) The human 11q13 region, where humanMALAT1
is located, is a ‘‘RIDGE’’ chromosome domain of very high gene
density and gene expression that supports strong transcription
activity of inserted transgenes (Gierman et al., 2007) and has
a very decompact higher-order chromatin structure (Gilbert
et al., 2004). (3) The homologous recombination frequency is
exceptionally high for both Malat1 (this study) and Neat1
(B.Z. and D.L.S., unpublished data). (4) Malat1 is frequently
translocated in renal carcinoma and embryonic sarcoma (Davis
et al., 2003; Rajaram et al., 2007). (5)Malat1 is the most favored
hotspot for HIV integration mediated by the ING2–IBD fusion
(Ferris et al., 2010) and is among the top targets of activation-
induced cytidine deaminase (AID) with accumulated mutations
as frequent as the Ig locus after AID activation in B cells (Kato
et al., 2012). Taken together, the high susceptibility for recombi-
nation, translocation, and DNA breaks is most likely associated
with a distinct chromatin structure and/or histone modifications
of the locus, which is responsible for its high transcriptional
activity. Given these characteristics, this genomic locus could
be utilized to efficiently knock in any transgene of interest
to achieve stable and high expression in most tissues and
cell types.
The specific subcellular localization ofMalat1 has led some to
suggest that this RNA could function along with speckle-associ-
ated protein factors (i.e., SRSF1 and SRSF2) and other nuclear
proteins to regulate cell- and tissue-specific gene expression
and/or pre-mRNA splicing. In this regard, two recent studiesut Its Transcription Inactivation Alters Gene Expression in cis
of each exon and their statistical significance [y axis,log10(FDR)] uponMalat1
nd lncRNA (red) genes in wild-type andMalat1mutant livers and brain cortices.
s. WT, wild-type (Malat1+/+); KO, knockout (Malat1/).
r but not at the exact scale. Upregulated genes with statistical significance after
sting correction (green). Sssca1 expression is not significantly altered. Vertical
romosome; vertical bars above the line represent transcription from the positive
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have revealed different phenotypes upon Malat1 knockdown
in HeLa cells. Tripathi et al. (2010) demonstrated that knockdown
ofMalat1 resulted in aG2/M phase arrest and significant levels of
cell death in both human HeLa cells and mouse EpH4 cells
(Tripathi et al., 2010). Contrary to this finding, Yang et al. (2011)
showed that Malat1 depletion resulted in a G1/S phase arrest
(Yang et al., 2011). However, we have found that Malat1
knockout mice are viable and fertile, with no obvious gross
abnormalities, and their cells do not exhibit increased cell death
or defects in cell-cycle progression. This discrepancy of Malat1
function between in vitro and in vivo analyses could be due to
redundant compensatory mechanisms during development;
however, the transient knockdown of Malat1 in adult mouse
tissues and cultured cells by free uptake of ASOs in the absence
of any transfection reagent did not induce either cell death or
cell-cycle arrest.
The different cellular phenotypes observed in Malat1-
depleted HeLa cells, G2/M arrest/increased cell death versus
G1/S arrest, were explained by distinct molecular mechanisms
ofMalat1 in splicing versus gene expression, respectively (Tripa-
thi et al., 2010; Yang et al., 2011). Tripathi et al. (2010) demon-
strated that Malat1 regulates pre-mRNA splicing through
modulating the pre-mRNA splicing factor level and the phos-
phorylation status of one or more SR family splicing factors
(Tripathi et al., 2010). In contrast, Yang et al. (2011) showed
that Malat1 interacts with unmethylated Pc2 to promote E2F1
target gene expression during cell-cycle progression (Yang
et al., 2011). However, our cellular, biochemical, and molecular
analyses showed no significant changes in the level and/or
phosphorylation status of SR proteins or global splicing patterns
inMalat1-depleted human and mouse cells and tissues. We also
did not see global changes of steady-state mRNA levels or E2F1
target gene misregulation upon Malat1 depletion in mouse liver
and cortex. Furthermore, neither cell death nor alterations in
proliferation were observed when Malat1 was knocked down
using free-uptake ASOs. Taken together, our data on mouse
tissues and mouse and human cells suggest that loss of
Malat1 does not alter global pre-mRNA splicing and/or gene
expression.
Although we did not observe changes in either global gene
expression or alternative pre-mRNA splicing in the Malat1
knockout mutants, we did identify a small number of genes
with statistically significant changes in expression in liver and
brain cortex. For example, Neat1 is upregulated by 1.5- to
2-fold in both liver and cortex, suggesting a potential compen-
sation between Malat1 and Neat1. Interestingly, among the 12
genes with statistically significant changes in expression level
upon inactivation of the Malat1 gene in brain cortex, five of
these genes reside adjacent to Malat1 and are upregulated by
1.5- to 2.3-fold. Furthermore, several additional genes in
the proximity of Malat1 also showed significant upregulation
when statistical analysis was performed without the use of a
multiple-testing correction against the entire genome. This cis
effect on gene expression is similar to the effect observed
upon loss of imprinting lncRNAs, such as Air (Sleutels et al.,
2002). However, so far there is no evidence in support of the
role of the Malat1 locus in imprinting. Since we did not see
Neat1 expression changes upon depletion of Malat1 RNA by120 Cell Reports 2, 111–123, July 26, 2012 ª2012 The AuthorsASO treatment in liver and small intestine, this cis effect is prob-
ably not mediated by Malat1 RNA itself, implying a different
mechanism than imprinting. The syntenic conservation and
strong transcription of the Malat1 locus from fish to human
suggest that transcription of the Malat1 gene may carry a func-
tion that is under selective constraints during evolution. This
may also explain why the Malat1 primary sequence is very
divergent between fish and human except for the 30 end
tRNA-like processing module. Several mechanisms underlying
ncRNA transcription-mediated cis gene regulation have been
recently identified. It has been demonstrated that transcription
of ncRNA genes can directly interfere with downstream or over-
lapping gene transcription by altering transcription factor
binding at the yeast SER3, FLO11, and IME4 loci (Bumgarner
et al., 2012; Hongay et al., 2006; Martens et al., 2004) and the
Drosophila Ubx locus (Petruk et al., 2006). This mechanism is
called transcriptional interference, the direct negative influence
of one transcriptional process on a second transcriptional
process in cis (reviewed in Shearwin et al., 2005). Moreover,
the act of ncRNA transcription can also induce histone modifi-
cations and thus indirectly alter the overlapping or neighboring
gene transcription, as demonstrated at the budding yeast
PHO84 locus (Camblong et al., 2007), GAL1-10 gene clusters
(Houseley et al., 2008), and the fbp1+ locus in S. pombe (Hirota
et al., 2008). Given that a number of Malat1 neighboring genes
showed significant upregulation upon Malat1 inactivation and
that Malat1 transcription does not overlap with any nearby
protein-coding genes, the cis effect may be attributed to altered
histone modification, which could have a broad impact on local
chromatin organization. Alternatively, the strong Malat1
promoter activity may sequester RNA pol II from its adjacent
genes, thereby modulating their expression in wild-type cells.
However, we cannot rule out the possibility that the deleted
3 kb region of the Malat1 gene contains cis DNA elements
that negatively regulate expression of genes adjacent toMalat1.
In addition, given the distinct subnuclear localization and high
abundance of the Malat1 lncRNA and its conservation in
mammals, it is highly likely that the Malat1 transcripts will also
exhibit a trans effect in mouse tissues under specific physiolog-
ical conditions. Examining these possibilities merits future
investigation.
Taken together, our in vivo and in vitro studies demonstrate
that Malat1 is not essential for mouse pre- and postnatal devel-
opment and that its deletion does not affect global gene expres-
sion and pre-mRNA splicing under the conditions examined.
Among a small number of genes with significant changes in
expression in mouse liver and cortex, a significant number of
these genes are Malat1 neighboring genes. Despite being
dispensable for development, the unique features of Malat1,
syntenic conservation, high abundance, conserved 30 end pro-
cessing, specific nuclear localization, and developmental regula-
tion, argue for a broader functional role for this lncRNA. A lack
of phenotype upon the loss of Malat1 lncRNA transcripts could
be attributed to functional redundancy with other RNA tran-
scripts (e.g., Neat1 lncRNA) or to compensatory mechanisms
during development, as occurs with respect to many protein-
coding genes. Alternatively, some lncRNAs, including Malat1,
could have a subtle role and regulate cellular processes via
a fine-tuning mechanism. Given the initial identification ofMalat1
as a gene whose upregulation was correlated with tumors that
have the propensity to metastasize (Ji et al., 2003), it will be
important to investigate the potential role of Malat1 in cancer
progression and upon other pathological stresses.
EXPERIMENTAL PROCEDURES
All animal protocols have been approved by the CSHL Animal Care and Use
Committee.
In Vivo Knockdown of Malat1
Male Balb/c mice (n = 4) 7 weeks of age were subcutaneously dosed with
saline, Malat1 ASO1, or Malat1 ASO2 (sequence information in Table S5) at
100 mg/kg/week for 4 weeks. At 24 hr after the last dose, the animals were
sacrificed. The liver and small intestine were harvested and homogenized in
RLT buffer (QIAGEN) containing 1% 2-mercaptoethanol. Total mRNA was
prepared with the PureLink Total RNA Purification Kit (Invitrogen) according
to the manufacturer’s instruction. A second set of tissues were fixed in 10%
buffered formalin for 72 hr and further paraffin embedded and sectioned at
4 mm for histology and RNA in situ hybridization analysis with the Affymetrix
QuantiGene ViewRNA Assay.
Generation of Malat1 Knockout Mice
Malat1-deficient mice were generated by homologous recombination,
and genotypes were determined by Southern blot and PCR analyses
(sequence information in Table S5; see details in Extended Experimental
Procedures).
RNA-seq Expression and Splicing Analyses
Raw reads obtained from the Illumina pipeline were mapped back to the
mouse reference genome (NCBI37/mm9) together with a comprehensive
database of annotated exon junctions with the use of the program OLego
(J.W. and C.Z., unpublished data, http://ngs-olego.sourceforge.net/). Only
those reads that were mapped to unique loci with% 4 mismatches (substitu-
tions, insertions, or deletions) were used for further analysis. For junction
reads, we required R 8 nt matches on each side for novel junctions
and R 5 nt matches on each side for known junctions. Transcript structure
of each cDNA fragment unobserved between the paired ends due to alterna-
tive splicing was then inferred with the use of a Bayes method, followed by
analysis of alternative splicing in 13,000 annotated cassette exons in the
mouse genome (K. Charizanis and M.S. Swanson, unpublished data). In brief,
fragments of the biological replicates were first pooled together, and cassette
exons were then filtered by junction fragment coverage to reduce multiple
testing (junction_in + junction_skip R 20, junction_WT + junction_KO R 20).
A Fisher’s exact test was performed to evaluate the statistical significance of
splicing change using exon or exon-junction fragments, followed by Benjamini
multiple-testing correction to estimate the FDR. In addition, proportional
change of exon inclusion (DI) was calculated using inclusion or skipping
junction fragments.
We analyzed the mRNA steady-state level of 18,974 protein-coding genes
and 1,722 lncRNAs. For protein-coding genes, we defined a set of nonover-
lapping ‘‘core’’ exons, which consists of a comprehensive collection of
annotated exons in RefSeq and UCSC known genes, as well as in mRNA
and EST sequences; exons showing an inclusion level < 0.5, as estimated
from mRNA and EST data, were excluded. LncRNA genes were obtained
from RefSeq on the basis of the annotated gene type ‘‘miscRNA.’’ A vast
majority of these ncRNAs in this collection are long and have multiple exons,
but the collection also includes miRNAs and scaRNAs, which were excluded
for this study. The remaining transcripts are from 1,722 unique loci, and all
exons were used to estimate gene expression level. To estimate FPKM
values, the number of fragments overlapping with exons in each gene was
counted, normalized by the total length of core exons and the total number
of exonic reads in all genes. Statistical significance of differential expression
was assessed by the edgeR program (Robinson et al., 2010) using fragment
counts in each sample.SUPPLEMENTAL INFORMATION
Supplemental Information includes Extended Experimental Procedures, six
figures, and five tables and can be found with this article online at http://dx.
doi.org/10.1016/j.celrep.2012.06.003.
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While our manuscript was in press, two additional studies describing similar
phenotypes for the Malat1knockout mice came to our attention from the labo-
ratories of Sven Diederichs (Eissmann et al., 2012) and Shinichi Nakagawa and
Kannanganattu Prasanth (Nakagawa et al., 2012):
Eissmann, M., Gutschner, T., Hammerle, M., Gunther, S., Caudron-Herger,
M., Gross, M., Schirmacher, P., Rippe, K., Braun, T., Zornig, M., et al. (2012).
Loss of the abundant nuclear non-coding RNA MALAT1 is compatible with life
and development. RNA Biol. 10.4161/rna.21089.
Nakagawa, S., Ip, J.Y., Shioi, G., Tripathi, V., Zong, X., Hirose, T. and K.V.
Prasanth. (2012). Malat1 is not an essential component of nuclear speckles
in mice. RNA. 10.1261/rna.033217.112.Cell Reports 2, 111–123, July 26, 2012 ª2012 The Authors 123
